Navigation
Hair Loss News Archives
October 2010
CUMC Professor Discovers Genetic Basis for Hair Loss
Unlike male-pattern baldness, alopecia areata has a sudden onset and is often marked by hair loss from the entire body, including the eyebrows, eyelashes and legs
Oct 2010
Physician, heal thyself.” That oft-quoted proverb describes the
ground-breaking effort by Columbia professor Angela Christiano to
discover the cause of the second most common form of hair loss after
male-pattern baldness.
In 1996, Christiano’s hair suddenly began falling out, leaving her
scalp riddled with bald patches. The condition was diagnosed as
alopecia areata, which affects about 2 percent of the population
overall including more than 5.3 million people in the United States.
As she struggled with the disease, Christiano, who is affiliated
with the Dermatology and the Genetics and Development departments at
Columbia University Medical Center, decided to study hair loss.
“I looked at the literature and realized how little was known about
genes that control hair growth,” she says. “I couldn’t believe that
this disease I was living with was so much in the dark.”
Earlier this year, an international team of researchers led by
Christiano found that the immune genes carried by alopecia areata
patients are nearly identical to those carried by patients suffering
from rheumatoid arthritis, Type 1 diabetes and celiac disease. The
study was published in the July 1 issue of Nature.
Christiano, the Richard and Mildred Rhodebeck Professor of
Dermatology, is now hopeful that the drugs used to treat those
diseases—particularly rheumatoid arthritis—might also be used to
treat alopecia areata. The team expects to begin clinical trials
next year.
Unlike male-pattern baldness, alopecia areata has a sudden onset and
is often marked by hair loss from the entire body, including the
eyebrows, eyelashes and legs. (The word “alopecia ” comes from the
Greek word for “fox,” an animal that frequently loses its hair.) The
disease is classified as an autoimmune disorder, which means it’s
caused when the body’s immune system attacks its own organs—in this
case, the hair follicles.
The researchers discovered that a gene called ULBP3 acts as a homing
beacon for killer immune cells. ULBP3 is turned off in normal hair
follicles but turned on in alopecia areata follicles. In its
activated state, ULBP3 attracts killer immune cells with a special
receptor called NKG2D, which triggers an autoimmune attack.
Christiano and colleague Raphael Clynes, an assistant professor of
medicine and microbiology at the medical center, are now trying to
find a way to moderate the response.
“The easy thing to do would be to block the NKG2D receptor using
certain antibody drugs that are currently being developed,” says
Clynes. “The other tactic is to use a soluble receptor that … blocks
the interaction between the killer cells and the ULBP3’s ‘kill-me’
signal.”
In addition to hair loss, Christiano studies hypertrichosis, or
excess hair growth. She earned her Ph.D. in genetics at Rutgers
University and was a post-doctoral fellow in dermatology at
Jefferson Medical Center in Philadelphia, where she performed
research in epidermolysis bullosa, a potentially fatal blister
disorder.
Hair loss is among the most emotionally devastating skin diseases,
as measured by impact on quality of life, says Christiano. For now,
she says, alopecia patients should take comfort in knowing the
disease has a genetic cause, which means that help may be on the
way.
Today, Christiano has a full head of dark, wavy hair. After two
years of treatment with steroids, the condition reversed itself. But
she remains emotionally connected to the disease.
She recently spoke at a National Alopecia Areata Foundation patient
conference in Indianapolis. After delivering a lecture to several
hundred alopecia patients, many people burst into tears—and she did
too.
“They finally had genes to talk about,” she says. “They felt
empowered.”
Source